Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.

Yuan ChengFei MoQingfang LiXuejiao HanHouhui ShiSiyuan ChenYuquan WeiXiawei Wei

Published in: Molecular cancer (2021)

Our finds verify the therapeutic effects of targeting CXCR2 in lung cancer and uncover the potential mechanism for the increased sensitivity to chemotherapeutic agents by antagonists of CXCR2.

Keyphrases

cell migration
cancer therapy
drug delivery
human health
risk assessment